Table 1 Characteristics of the study population, total and by the presence of prevalent myocardial infarction

N

3001

2767

229

Age, year

72.71 ± 9.36

72.40 ± 9.39

76.26 ± 8.31

Sex (female)

1,697 (57)

1,633 (59)

60 (26)

Caucasian

2,775 (96)

2,555 (96)

215 (97)

Smoking status

 Never

952 (32)

915 (33)

35 (16)

 Former

1,619 (55)

1,460 (53)

159 (72)

 Current

388 (13)

359 (13)

28 (13)

Body mass index, kg/m²

27.55 ± 4.30

27.49 ± 4.32

28.20 ± 4.01

Waist-hip ratio

0.90 ± 0.09

0.90 ± 0.09

0.96 ± 0.10

Total cholesterol, mmol/L

5.45 ± 1.10

5.52 ± 1.08

4.56 ± 1.01

HDL, mmol/L

1.44 (1.20, 1.74)

1.45 (1.20, 1.76)

1.26 (1.09, 1.48)

Triglycerides, mmol/L

1.27 (0.97, 1.72)

1.27 (0.98, 1.73)

1.28 (0.96, 1.72)

Lipid lowering medication

916 (31)

737 (27)

178 (80)

Dyslipidemia

1562 (54)

1364 (51)

197 (89)

eGFR, mL/min per 1.73 m²

74.94 (65.49, 84.46)

75.34 (65.96, 84.62)

70.16 (57.88, 81.22)

Chronic kidney disease

431 (15)

366 (14)

64 (29)

Diabetes

413 (14)

365 (13)

47 (21)

Mean intima-media thickness, mm

0.92 ± 0.16

0.92 ± 0.15

0.98 ± 0.18

Max intima-media thickness, mm

1.05 ± 0.19

1.04 ± 0.19

1.14 ± 0.23

Pulse wave velocity, m/s

11.10 (9.88, 12.62)

11.03 (9.85, 12.54)

11.86 (10.57, 13.37)

CAC score (EBT)

48.74 (3.61, 227.69)

32.50 (3.09, 182.38)

322.60 (79.30, 819.52)

Absent, mild, moderate, severe EBT-CAC scores (n)

73, 201, 101, 80

71, 190, 89, 58

2, 11, 12, 22

CAC score (MDCT)

77.40 (4.95, 363.32)

57.45 (3.18, 294.02)

541.80 (118.00, 1,397.60)

Absent, mild, moderate, severe MDCT-CAC scores (n)

52, 116, 75, 75

52, 107, 69, 56

0, 8, 6, 19

SBP, mmHg

139.08 ± 19.77

139.24 ± 19.90

137.20 ± 18.12

DBP, mmHg

76.45 ± 11.09

76.73 ± 11.09

73.12 ± 10.65

Use of blood pressure lowering medication

1,577 (53)

1,368 (50)

209 (92)

Hypertension

2,166 (72)

1,949 (70)

217 (95)

Presence of carotid plaques

2469 (85.7)

2257 (84.8)

209 (95.9)

Plaque score

2 (1, 4)

2 (1, 4)

4 (3, 5)

SAF, A.U

2.40 ± 0.49

2.38 ± 0.48

2.64 ± 0.52